1. A new Nitrofuran derivate, 3-di (hydroxylmethyl)-amino-6 (5'-nitrofurylethenyl)-1. 2. 4-triazine (Panfuran 5) was administered to 39 cases of bacillary dysentery.
2. In order to avoid side effects, these cases were divided into 3 groups of the following daily dosis; 8 mg/Kg, 16 mg/Kg and 32 mg/Kg, for 5 days, respectively.
3. A marked effect (decrease in the number of stools) was not recognized against diarrhea in the acute stage of severe and moderate cases of the 3 groups.
4. Bacilli disappeared in each group within 10 days. It was also the case with anitibiotic-resistant strains.
5. Reappearance of bacilli was observed in 50% of the 8 mg/Kg group, in 36% of the 16 mg/Kg group and in 14% of the 32 mg/Kg group. This tendency, decrease of reappearance rate with increased dosis, was also observed in cases due to antibioticresistant strains, no reappearance of bacilli in the 2 cases of the 32 mg/Kg group.
6. Consequently, Panfuran S without side effects in daily dosis, 32 mg/Kg or more should be considered in therapy of bacillary dysentery, especially due to antibioticresistant strains.
View full abstract